Monica Fradkin on Improving Staff Communication for Patients in Clinical Trials
Monica Fradkin, RN, MPH, Smilow Cancer Hospital at Yale-New Haven, discusses improving communication between clinical staff and research staff for patients who are approved for clinical trials.
Monica Fradkin, RN, MPH, Smilow Cancer Hospital at Yale-New Haven, discusses improving communication between clinical staff and research staff for patients who are approved for clinical trials.
A cross-organizational communication system was established between the hospital and Yale with the common goal of safely treating patients in clinical trials and providing high-quality research care.
To accomplish this, a number of aspects were established, such as hand-off tools, clinical staff education, and documentation tools in the electronic medical records. Also, there is now better communication between the two institutions, ensuring that any information on new clinical trials is given to the treating nurses whose patients may be eligible.
Olaparib Plus Chemo May Not Improve Outcomes vs Chemo Alone in BRCA Wild-Type TNBC
April 23rd 2024Patients with BRCA wild-type triple-negative breast cancer treated with olaparib on a gap schedule with chemotherapy did not experience improved responses compared with chemotherapy alone in the neoadjuvant setting.
